Allosecurinin
CAS No. 884-68-4
Allosecurinin( —— )
Catalog No. M20496 CAS No. 884-68-4
Allosecurinine has Antifungal Activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 74 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 161 | In Stock |
|
| 50MG | 233 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAllosecurinin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAllosecurinine has Antifungal Activity.
-
DescriptionAllosecurinine has Antifungal Activity.
-
In VitroSecurinega alkaloids are a class of natural products found in a small number of Phyllanthaceae species, and exhibits important biological activities, such as stimulating the Central Nervous System (CNS) and antitumor, anti-malarial and antibacterial activities.
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntifungal
-
RecptorAntifungal
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number884-68-4
-
Formula Weight217.26
-
Molecular FormulaC13H15NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (230.14 mM)
-
SMILESO=C1OC23CC(C=CC2=C1)N1CCCCC31
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
LW3
LW3 is an effective broad-spectrum antifungal compound. LW3 showed antifungal activity against B. cinerea, R. solani, S. sclerotiorum and F. graminearum, with EC50 values of 0.54, 0.09, 1.52 and 2.65 mg/L, respectively.
-
Embeconazole
Embeconazole (R 120758) is a triazole antifungal agent.Embeconazole has strong in vitro activity against clinically important fungi such as Candida, Aspergillus and Cryptococcus neoformans.
-
Butoconazole
Butoconazole is an imidazole antifungal agentButoconazole is particularly effective against in vivo Candida albicans infections (mice), maintaining good activity down to 0.25% formulation strength and showing unusually low reinfection rates after treatment is ended.
Cart
sales@molnova.com